To the best of our knowledge, this is the first frequency study using a combination of infection diagnostic techniques (p16 IHC and PCR HPV-DNA) and applying the latest site/histological-coding systems to a sample of OSCCs, according to the most recent academic indications (2021 NIH/SEER ICD-0-3.2). This evidence concerns the gene CDKN2A and infection.